By avoiding big swings, low-volatility stocks let investors focus on long-term fundamentals. These stocks may not be up 100% in a single year, but they offer a measured approach to building wealth over time.
But not all investments are created equal, which is why we built StockStory - to help you separate the winners from the losers. Keeping that in mind, here are three low-volatility stocks that could succeed under all market conditions.
Vital Farms (VITL)
Rolling One-Year Beta: 0.59
With an emphasis on ethically produced products, Vital Farms (NASDAQ:VITL) specializes in pasture-raised eggs and butter.
Why Is VITL a Top Pick?
- Unit sales were phenomenal over the past two years, showing demand is robust and retailers can’t stock enough of its products
- Notable projected revenue growth of 26.7% for the next 12 months hints at market share gains
- Earnings per share grew by 161% annually over the last three years and trumped its peers
At $38.90 per share, Vital Farms trades at 28.3x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.
Cadre (CDRE)
Rolling One-Year Beta: 0.87
Originally known as Safariland, Cadre (NYSE:CDRE) specializes in manufacturing and distributing safety and survivability equipment for first responders.
Why Are We Fans of CDRE?
- Annual revenue growth of 9.7% over the last two years beat the sector average and underscores the unique value of its offerings
- Market share is on track to rise over the next 12 months as its 17.6% projected revenue growth implies demand will accelerate from its two-year trend
- Earnings per share grew by 19.7% annually over the last two years, massively outpacing its peers
Cadre’s stock price of $32.23 implies a valuation ratio of 20.3x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Zoetis (ZTS)
Rolling One-Year Beta: 0.29
Originally spun off from Pfizer in 2013 as the world's largest pure-play animal health company, Zoetis (NYSE:ZTS) discovers, develops, and sells medicines, vaccines, diagnostic products, and services for pets and livestock animals worldwide.
Why Does ZTS Catch Our Eye?
- Business is well-positioned no matter the global macroeconomic backdrop as its constant currency revenue growth averaged 9.1% over the past two years
- Robust free cash flow margin of 21.4% gives it many options for capital deployment
- ROIC punches in at 28.8%, illustrating management’s expertise in identifying profitable investments
Zoetis is trading at $159.18 per share, or 25.8x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today